T1	DrugClass 245 291	drugs that act on the renin-angiotensin system
T2	AdverseReaction 344 372	reduces fetal renal function
T3	AdverseReaction 387 392;406 415	fetal morbidity
T4	AdverseReaction 387 392;420 425	fetal death
T5	AdverseReaction 397 415	neonatal morbidity
T6	AdverseReaction 397 405;420 425	neonatal death
T7	AdverseReaction 437 452	oligohydramnios
T8	AdverseReaction 476 497	fetal lung hypoplasia
T9	AdverseReaction 476 481;502 523	fetal skeletal deformations
T10	Factor 453 456	can
T11	AdverseReaction 535 559	neonatal adverse effects
T12	AdverseReaction 535 543;568 584	neonatal skull hypoplasia
T13	AdverseReaction 535 543;586 592	neonatal anuria
T14	AdverseReaction 535 543;594 605	neonatal hypotension
T15	AdverseReaction 535 543;607 620	neonatal renal failure
T16	AdverseReaction 535 543;626 631	neonatal death
T17	Factor 525 534	Potential
T18	AdverseReaction 965 988	symptomatic hypotension
T19	Factor 989 992	may
T21	AdverseReaction 1557 1582	changes in renal function
T22	Factor 1583 1586	may
T23	AdverseReaction 1956 1964	oliguria
T24	AdverseReaction 1968 1988	progressive azotemia
T25	AdverseReaction 2005 2024	acute renal failure
T26	AdverseReaction 2029 2034	death
T27	DrugClass 1856 1896	angiotensin-converting enzyme inhibitors
T28	DrugClass 1901 1930	angiotensin receptor blockers
T29	AdverseReaction 2298 2327	increases in serum creatinine
T30	AdverseReaction 2298 2310;2331 2350	increases in blood urea nitrogen
T31	DrugClass 2219 2233	ACE inhibitors
E1	DrugClass:T1
E2	AdverseReaction:T2 Hypothetical:E1
E3	AdverseReaction:T3 Hypothetical:E1
E4	AdverseReaction:T4 Hypothetical:E1
E5	AdverseReaction:T5 Hypothetical:E1
E6	AdverseReaction:T6 Hypothetical:E1
E7	AdverseReaction:T7
E8	AdverseReaction:T8 Hypothetical:E10
E9	AdverseReaction:T9 Hypothetical:E10
E10	Factor:T10
E11	AdverseReaction:T11 Hypothetical:E17
E12	AdverseReaction:T12 Hypothetical:E17
E13	AdverseReaction:T13 Hypothetical:E17
E14	AdverseReaction:T14 Hypothetical:E17
E15	AdverseReaction:T15 Hypothetical:E17
E16	AdverseReaction:T16 Hypothetical:E17
E17	Factor:T17
E18	AdverseReaction:T18 Hypothetical:E19
E19	Factor:T19
E21	AdverseReaction:T21 Hypothetical:E22
E22	Factor:T22
E23	AdverseReaction:T23 Hypothetical:E27 Hypothetical2:E28
E24	AdverseReaction:T24 Hypothetical:E27 Hypothetical2:E28
E25	AdverseReaction:T25 Hypothetical:E27 Hypothetical2:E28
E26	AdverseReaction:T26 Hypothetical:E27 Hypothetical2:E28
E27	DrugClass:T27
E28	DrugClass:T28
E29	AdverseReaction:T29 Hypothetical:E31
E30	AdverseReaction:T30 Hypothetical:E31
E31	DrugClass:T31
A1	flag E2 underspecified
A2	CUI E2 C0232807
A3	UMLS-Preferred-Name E2 Decreased renal function
A4	MEDDRA-PT E2 Renal impairment
A5	MEDDRA-PT-ID E2 10062237
A6	LLT E2 Function kidney decreased
A7	LLT-ID E2 10017474
A8	CUI E3 C0015929
A9	UMLS-Preferred-Name E3 Fetal Diseases
A10	MEDDRA-PT E3 Foetal disorder
A11	MEDDRA-PT-ID E3 10061157
A12	LLT E3 Fetal disorder
A13	LLT-ID E3 10016485
A14	CUI E4 C0015927
A15	UMLS-Preferred-Name E4 Fetal Death
A16	MEDDRA-PT E4 Foetal death
A17	MEDDRA-PT-ID E4 10055690
A18	LLT E4 Fetal death
A19	LLT-ID E4 10016479
A20	CUI E5 C0848898
A21	UMLS-Preferred-Name E5 newborn morbidity
A22	MEDDRA-PT E5 Neonatal disorder
A23	MEDDRA-PT-ID E5 10028934
A24	CUI E6 C0410916
A25	UMLS-Preferred-Name E6 Neonatal Death
A26	MEDDRA-PT E6 Death neonatal
A27	MEDDRA-PT-ID E6 10011912
A28	CUI E7 C0079924
A29	UMLS-Preferred-Name E7 Oligohydramnios
A30	MEDDRA-PT E7 Oligohydramnios
A31	MEDDRA-PT-ID E7 10030289
A32	CUI E8 C0265783
A33	UMLS-Preferred-Name E8 Congenital hypoplasia of lung
A34	MEDDRA-PT E8 Pulmonary hypoplasia
A35	MEDDRA-PT-ID E8 10037407
A36	LLT E8 Agenesis, hypoplasia, and dysplasia of lung, congenital
A37	LLT-ID E8 10001479
A38	CUI E9 C0000768
A39	UMLS-Preferred-Name E9 Congenital Abnormality
A40	MEDDRA-PT E9 Congenital anomaly
A41	MEDDRA-PT-ID E9 10010356
A42	CUI E11 C0549411
A43	UMLS-Preferred-Name E11 Neonatal adverse effect
A44	MEDDRA-PT E11 Neonatal disorder
A45	MEDDRA-PT-ID E11 10028934
A46	CUI E12 C1390484
A47	UMLS-Preferred-Name E12 Skull hypoplasia
A48	MEDDRA-PT E12 Microcephaly
A49	MEDDRA-PT-ID E12 10027534
A50	LLT E12 Skull hypoplasia
A51	LLT-ID E12 10073498
A52	CUI E13 C0877643
A53	UMLS-Preferred-Name E13 Neonatal anuria
A54	MEDDRA-PT E13 Neonatal anuria
A55	MEDDRA-PT-ID E13 10049778
A56	CUI E14 C0455995
A57	UMLS-Preferred-Name E14 Neonatal hypotension
A58	MEDDRA-PT E14 Neonatal hypotension
A59	MEDDRA-PT-ID E14 10049223
A60	CUI E15 C0854351
A61	UMLS-Preferred-Name E15 Renal failure neonatal
A62	MEDDRA-PT E15 Renal failure neonatal
A63	MEDDRA-PT-ID E15 10038447
A64	CUI E16 C0410916
A65	UMLS-Preferred-Name E16 Neonatal Death
A66	MEDDRA-PT E16 Death neonatal
A67	MEDDRA-PT-ID E16 10011912
A68	CUI E18 C0863113
A69	UMLS-Preferred-Name E18 Hypotension symptomatic
A70	MEDDRA-PT E18 Hypotension
A71	MEDDRA-PT-ID E18 10021097
A72	LLT E18 Hypotension symptomatic
A73	LLT-ID E18 10021105
A74	CUI E21 C0151746
A75	UMLS-Preferred-Name E21 Abnormal renal function
A76	MEDDRA-PT E21 Renal impairment
A77	MEDDRA-PT-ID E21 10062237
A78	LLT E21 Renal function abnormal
A79	LLT-ID E21 10038451
A80	CUI E23 C0028961
A81	UMLS-Preferred-Name E23 Oliguria
A82	MEDDRA-PT E23 Oliguria
A83	MEDDRA-PT-ID E23 10030302
A84	flag E24 underspecified
A85	CUI E24 C0242528
A86	UMLS-Preferred-Name E24 Azotemia
A87	MEDDRA-PT E24 Azotaemia
A88	MEDDRA-PT-ID E24 10003885
A89	CUI E25 C0022660
A90	UMLS-Preferred-Name E25 Kidney Failure, Acute
A91	MEDDRA-PT E25 Acute kidney injury
A92	MEDDRA-PT-ID E25 10069339
A93	LLT E25 Acute renal failure
A94	LLT-ID E25 10001041
A95	CUI E26 C1306577
A96	UMLS-Preferred-Name E26 Death (finding)
A97	MEDDRA-PT E26 Death
A98	MEDDRA-PT-ID E26 10011906
A99	CUI E29 C0700225
A100	UMLS-Preferred-Name E29 Serum creatinine raised
A101	MEDDRA-PT E29 Blood creatinine increased
A102	MEDDRA-PT-ID E29 10005483
A103	LLT E29 Serum creatinine increased
A104	LLT-ID E29 10040233
A105	CUI E30 C0151539
A106	UMLS-Preferred-Name E30 Blood urea increased
A107	MEDDRA-PT E30 Blood urea increased
A108	MEDDRA-PT-ID E30 10005851
A109	LLT E30 BUN increased
A110	LLT-ID E30 10006576
